Methods of preventing the occurrence of cardiovascular events
AssigneeKowa Company, Ltd.
InventorsRyu Oshima, Gary Gordon
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmacological interventions with pemafibrate for cardiovascular diseases and adverse cardiovascular events. In addition, the invention relates to the use of pemafibrate to treat dyslipidemia and type 2 diabetes mellitus and thereby reduce the risk of cardiovascular disease and adverse cardiovascular events.
Claims19
A method of preventing the occurrence of cardiovascular events in a patient with one or more risk factors, wherein the patient is on concomitant lipid-lowering therapy other than concomitant moderate to high intensity statin therapy and has an LDL-C concentration ≤70 mg/dL, comprising administering to the patient a therapeutically effective amount of pemafibrate or a pharmaceutically acceptable salt thereof.
A method of preventing the occurrence of cardiovascular events in a patient with one or more risk factors, wherein the patient has an LDL-C concentration ≤70 mg/dL, comprising administering to the patient a therapeutically effective amount of pemafibrate or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.